When controlling for the daily neratinib dose, the crofelemer BID and QID treated groups had a significant reduction in the average number of weekly loose/watery stools on week 2, while a statistical trend was noted over the entire 4-week study period ( Table 3 ).
← all excerpts
Effects of orally administered crofelemer on the incidence and severity of neratinib-induced diarrhea in female dogs.
1
—
—